MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028
TABLE
OF CONTENTS
1. MIDDLE
EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY INSIGHTS
2.2.1. KEY
PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE
IN SCREENING TESTS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE
OF USE
2.4.3. SECURITY
2.4.4. COST
EFFECTIVENESS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. KEY
MARKET STRATEGIES
2.8.1. ACQUISITIONS
2.8.2. PRODUCT
LAUNCHES
2.8.3. CONTRACTS
& AGREEMENTS
2.8.4. INVESTMENTS
& EXPANSIONS
2.9. MARKET
DRIVERS
2.9.1. NEED
TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.9.2. RISE
IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.10. MARKET
CHALLENGES
2.10.1. DELAYED
APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.10.2. USE OF
OPEN-SOURCE SOFTWARE
2.11. MARKET
OPPORTUNITIES
2.11.1. INCREASING
DEMAND FOR VACCINES AND PHARMACEUTICALS
2.11.2. DATA
MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.11.3. ACQUISITIONS
IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. MIDDLE
EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE
I
3.2. PHASE
II
3.3. PHASE
III
3.4. PHASE
IV
4. MIDDLE
EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL
TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE
SERVICES
4.3. PATIENT
RECRUITMENT MANAGEMENT
4.4. REGULATORY
SERVICES
4.5. DATA
MANAGEMENT
4.6. OTHER
SERVICES
5. MIDDLE
EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL
DEVICE COMPANIES
5.3. OTHER
SPONSORS
6. MIDDLE
EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET – COUNTRY OUTLOOK
6.1. UNITED
ARAB EMIRATES
6.2. SAUDI
ARABIA
6.3. TURKEY
6.4. SOUTH
AFRICA
6.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON
PLC
7.4. SYNEOS
HEALTH
7.5. LABCORP
DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES
RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI
CRO
7.12. WORLDWIDE
CLINICAL TRIALS
7.13. CTI
CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI APPTEC
7.15. ADVANCED
CLINICAL
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE
LIST
TABLE 1: MIDDLE EAST
AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028
(IN $ MILLION)
TABLE 2: LIST OF
COLLABORATIONS
TABLE 3: VENDOR
SCORECARD
TABLE 4: LIST OF
ACQUISITIONS
TABLE 5: LIST OF
PRODUCT LAUNCHES
TABLE 6: LIST OF
CONTRACTS & AGREEMENTS
TABLE 7: LIST OF
INVESTMENTS & BUSINESS EXPANSIONS
TABLE 8: LIST OF
PANDEMIC OUTBREAKS
TABLE 9: LIST OF
OPEN-SOURCE SOFTWARE
TABLE 10: LAUNCH OF
MEDICAL DRUGS
TABLE 11: PROMISING
ACQUISITIONS IN THE MARKET
TABLE 12: MIDDLE EAST
AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $
MILLION)
TABLE 13: MIDDLE EAST
AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028
(IN $ MILLION)
TABLE 14: MIDDLE EAST
AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $
MILLION)
TABLE 15: MIDDLE EAST
AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028
(IN $ MILLION)
FIGURE
LIST
FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET,
BY PHASE TYPE, 2021 & 2028 (IN %)
FIGURE 5: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET,
BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET,
BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET,
BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET,
BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET,
BY SERVICE, 2021 & 2028 (IN %)
FIGURE 10: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES
MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES
MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES
MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES
MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES
MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET,
BY OTHER SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES
MARKET, BY SPONSOR, 2021 & 2028 (IN %)
FIGURE 17: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES
MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $
MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES
MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES
MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES
MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 21: UNITED ARAB EMIRATES CLINICAL TRIALS SUPPORT SERVICES MARKET
2022-2028 (IN $ MILLION)
FIGURE 22: SAUDI ARABIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028
(IN $ MILLION)
FIGURE 23: TURKEY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE 24: SOUTH AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028
(IN $ MILLION)
FIGURE 25: REST OF MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT
SERVICES MARKET 2022-2028 (IN $ MILLION)
Investments from
leading global players would position the market in this region on a growth
path.
MARKET OUTLOOK
Triton Market Research’s
report on the clinical trials support services market in the Middle East and
Africa states that it is likely to develop with a CAGR of 7.20% during the
forecast phase from 2022 to 2028. Turkey, South Africa, Saudi Arabia, the
United Arab Emirates, and Rest of Middle East & Africa are evaluated in the
market in this region.
Numerous different
types of clinical research activities have been conducted in the United Arab
Emirates in recent years. These are sponsored mainly by government-affiliated
as well as private healthcare providers, and an increasing number of trials conducted
in the UAE have been registered internationally. Further, academic grants, pharmaceutical
sponsorships, and other endowments also account for clinical research funding
in the nation.
According to the Department
of Health officials, Abu Dhabi is well-positioned to become a leading destination
for clinical trials, gaining the attention of leading multinational life
sciences corporations due to its diverse population and strategic location. All
these factors indicate an overall positive outlook for the clinical trials
support services market.
Saudi Arabia conducts
15 trials per million people, compared to 341 trials per million people in the
United States. Despite the large population, excellent healthcare
infrastructure, and a high physician-to-patient ratio in the KSA, it still lags
behind other countries with comparable economies in terms of clinical research.
Saudi’s population has its own genetic characteristics. The key to attracting
biotechnology and pharmaceutical companies is to concentrate on specific
research areas of importance to the nation. This, in turn, would bolster the
clinical trials conducted and drive the demand for support services.
Get more insights into the Middle East and Africa Clinical
Trials Support Services Market:
COMPETITIVE OUTLOOK
Some of the acclaimed
players in the clinical trials support services market include Worldwide
Clinical Trials, Charles River Laboratories, WuXi AppTec, KCR, Alcura, Medpace,
ICON Plc, and Advanced Clinical.
SEGMENTATION
1. IQVIA
2. PAREXEL
3. ICON
PLC
4. SYNEOS
HEALTH
5. LABCORP
DRUG DEVELOPMENT
6. CLINIPACE
7. KCR
8. CHARLES
RIVER LABORATORIES
9. MEDPACE
10. ALCURA
11. PSI
CRO
12. WORLDWIDE
CLINICAL TRIALS
13. CTI
CLINICAL TRIAL AND CONSULTING SERVICES INC
14. WUXI
APPTEC
15. ADVANCED
CLINICAL
Comments
Post a Comment